CYREVIA

View On IPO.GOV.UK

Dead

on 18 May 2012

Last Applicant/ Owned by

Accentia Biopharmaceuticals, Inc.

324 S. Hyde Park Ave., Suite 350

Tampa,, , 33606

Serial Number

UK00910894251 filed on 18^th May 2012

Registration Number

UK00910894251 registered on
12^th Oct 2012

Correspondent Information

Gill Jennings & Every LLP

The Broadgate Tower, 20 Primrose Street

London,

EC2A 2ES

CYREVIA

pharmaceutical preparation, comprising intravenously administered cyclophosphamide, a cytotoxic drug, for the purpose of rebooting the immune system i Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparation, comprising intravenously administered cyclophosphamide, a cytotoxic drug, for the purpose of rebooting the immune system in the treatment and prevention of immune disorders.

Mark Details

Serial Number

UK00910894251

Mark Type

Word

Kind of mark

Individual

CYREVIA

Classification Information

Class [5]Pharmaceutical Products

Mark Details

Serial Number

Mark Type

Kind of mark

Class [5]
Pharmaceutical Products